Bausch Health Companies
Philip Sturno is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as VP of Global Research and Development at Bausch Pharmaceuticals since 2010. Sturno oversees a substantial R&D portfolio, leading a diverse team across multiple countries while handling portfolio expansion and technical production challenges. Prior roles include Vice President positions at Bausch & Lomb and Valeant Pharmaceuticals, where Sturno managed large global teams and advanced innovation in products for various medical applications. Additional expertise includes strategic advisory roles in product development for Padula Rehabilitation Therapies and Bain Advisor Network, along with significant contributions to Novartis and Schering-Plough Research Institute. Sturno holds an MBA in Finance and Operations from NYU Stern School of Business and a Bachelor's Degree in Mechanical Engineering from Drexel University College of Engineering.
This person is not in any teams
This person is not in any offices
Bausch Health Companies
21 followers
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.